FDA approves 'Natural Cycles' birth control app

Modesto Morganelli
Agosto 15, 2018

And, of course, there are always condoms. (Even then, abstinence and outercourse are the only birth control options that are 100 percent effective, according to Planned Parenthood.) Picking the right birth control for you and your partner is a highly personal choice-and it can take some time and some experimentation to find the best option.

Natural Cycles, a Swedish company, is the first app in the U.S.to be approved for this designation.

The U.S. Food and Drug Administration for the first time ever has green-lighted a birth control app to be marketed as a method of contraception. During clinical studies evaluating its effectiveness, more than 15,000 women used the app, with a reported failure rate of 1.8 percent with ideal use-meaning 1.8 out of 100 women doing exactly what the app told them to every day for a year still got pregnant. The typical use failure rate-which includes women not using the app correctly every day-was 6.5 percent. They can refrain from having sex-or use a condom or another birth control method-on these days, thus avoiding pregnancy.

The FDA confirmed the approval of the "contraception" designation for the mobile app "Natural Cycles" last week, which bills itself as providing an "algorithm that accurately detects and predicts ovulation and fertility".

Using data like daily body temperature and monthly menstrual cycle tracking, the app is said to have a fail rate of almost 2% for "perfect use", and a fail rate of 6% for "typical use", not unlike barrier methods and the pill.

For reference, male condoms have a failure rate of 18 percent, and oral contraceptives have a failure rate of 9 percent.

Sweden's public broadcasting company SVT reported that 37 out of 668 women who received an abortion at a Stockholm hospital from September 2017 to the end of December 2017 were using the app and still had an unwanted pregnancy. And though the Natural Cycles app boosts over 625,000 users, it has not been without controversy.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE